Maximus, Inc. operates as a provider of government services worldwide. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; subsidized telephone services; and person-centered independent assessment services. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The Outside the U.S. segment offers BPS and technology solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and technologies for modernization. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.

Maximus Inc.

Maximus ( ($MMS) ) has provided an update. On December 15, 2025, Maximus, Inc. announced that its Chief Legal Officer and Corporate Secretary, John...

Maximus Announces Upcoming Chief Legal Officer Transition

In a report released today, David Rescott from Robert W. Baird maintained a Buy rating on Merit Medical Systems, with a price target of $108.00. Re...

Merit Medical Systems (MMSI) Gets a Buy from Robert W. Baird

Mcmillan Shakespeare Limited ( ($AU:MMS) ) just unveiled an announcement. McMillan Shakespeare Limited announced a change in the director’s interes...

McMillan Shakespeare Announces Director’s Interest Change

Morgan Stanley analyst Chenny Wang maintained a Buy rating on Mcmillan Shakespeare Limited today and set a price target of A$21.50. According to Ti...

Current Quarter	$1.84	Next Quarter	$2.03
Current Year	$8.19	Next Year	$8.23
QoQ Growth	+10.3%	YoY Growth	+0.5%
3Y EPS CAGR	+2.4%	Target Price	$110.00
Consensus	Buy	Upside	+26.3%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MMS	$87.09	-1.33%	598.98K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MMS	$87.09	-1.3%	598.98K
3
4
5
6

MMS

MMS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Maximus Inc. Data in Excel

Get Maximus Inc. Data in Excel